69 related articles for article (PubMed ID: 38594742)
1. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
2. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
[TBL] [Abstract][Full Text] [Related]
3. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.
Karihtala P; Leivonen SK; Puistola U; Urpilainen E; Jääskeläinen A; Leppä S; Jukkola A
Breast Cancer Res; 2024 Apr; 26(1):61. PubMed ID: 38594742
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
5. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
[TBL] [Abstract][Full Text] [Related]
6. Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer.
Ye Q; Wang J; Ducatman B; Raese RA; Rogers JL; Wan YW; Dong C; Padden L; Pugacheva EN; Qian Y; Guo NL
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445737
[TBL] [Abstract][Full Text] [Related]
7. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
Di F; Wong NL
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
[TBL] [Abstract][Full Text] [Related]
8. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression.
Zahari S; Syafruddin SE; Mohtar MA
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174117
[TBL] [Abstract][Full Text] [Related]
10. A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer.
Dobilas A; Åkesson A; Leandersson P; Borgfeldt C
Cancer Genomics Proteomics; 2023; 20(3):273-280. PubMed ID: 37093685
[TBL] [Abstract][Full Text] [Related]
11. Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting.
Strati A; Markou A; Kyriakopoulou E; Lianidou E
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046848
[TBL] [Abstract][Full Text] [Related]
12. Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study.
Gunnarsdottir FB; Bendahl PO; Johansson A; Benfeitas R; Rydén L; Bergenfelz C; Larsson AM
Breast Cancer Res; 2023 Mar; 25(1):29. PubMed ID: 36945037
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial.
Lee ES; Kim Y; Shin HC; Hwang KT; Min J; Kim MK; Ahn S; Jung SY; Shin H; Chung M; Yoo TK; Jung S; Woo SU; Kim JY; Noh DY; Moon HG
Breast Cancer Res; 2023 Feb; 25(1):20. PubMed ID: 36788595
[TBL] [Abstract][Full Text] [Related]
14. Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer.
Roderburg C; Labuhn S; Bednarsch J; Lang SA; Schneider AT; Hammerich L; Vucur M; Ulmer TF; Neumann UP; Luedde T; Loosen SH
Mediators Inflamm; 2022; 2022():6195004. PubMed ID: 36505756
[TBL] [Abstract][Full Text] [Related]
15. The role of CXCR3 and its ligands in cancer.
Wang X; Zhang Y; Wang S; Ni H; Zhao P; Chen G; Xu B; Yuan L
Front Oncol; 2022; 12():1022688. PubMed ID: 36479091
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
